
    
      Patients will be enrolled concurrently according to one of two sets of criteria designated as
      Stratum I and Stratum II.

        1. Stratum I will enroll up to 24 subjects with low vision, inclusive of possible
           intermediate doses, in up to 4 cohorts of 3-6 evaluable subjects.

        2. Stratum II will enroll approximately 240 subjects with DME 1:1:1:1 in up to 4 cohorts of
           60 evaluable subjects.
    
  